OncoCyte Corporation
NASDAQ:OCX
3.08 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -27.781 | -72.902 | -64.097 | -29.932 | -22.426 | -15.754 | -19.375 | -11.168 | -8.735 | -4.986 | -3.495 |
| Depreciation & Amortization
| 1.68 | 5.22 | 4.205 | 1.898 | 0.351 | 0.559 | 0.58 | 0.387 | 0.283 | 0.281 | 0.277 |
| Deferred Income Tax
| 8.101 | 0 | -9.26 | -1.254 | 0.483 | 0.956 | 4.383 | 0 | 0.065 | 0 | -0.326 |
| Stock Based Compensation
| 2.887 | 10.042 | 6.841 | 5.066 | 2.995 | 1.479 | 1.63 | 0.922 | 1.815 | 0.318 | 0.326 |
| Change In Working Capital
| -3.971 | -1.942 | -2.204 | 0.399 | -1.555 | 0.993 | -0.686 | 2.337 | 2.325 | 3.223 | 2.182 |
| Accounts Receivables
| 0.109 | -0.575 | -1.229 | -0.182 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0.784 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -4.757 | 0.297 | -1.348 | 0.854 | 0.741 | 1.002 | -0.048 | 0.229 | 1.042 | 0.291 | 0.048 |
| Other Working Capital
| -0.107 | -1.664 | 0.373 | -0.273 | -2.296 | -0.009 | -0.638 | 2.108 | 1.283 | 2.932 | 2.134 |
| Other Non Cash Items
| -4.241 | 14.014 | 28.574 | -2.157 | 0.437 | 0.118 | 0.083 | 1.696 | 0.018 | 0.291 | 0.326 |
| Operating Cash Flow
| -23.325 | -45.568 | -35.941 | -25.98 | -19.715 | -11.649 | -13.385 | -7.522 | -4.229 | -1.164 | -0.71 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -0.281 | -4.34 | -2.247 | -1.227 | -0.918 | -0.031 | -0.091 | -0.106 | -0.5 | -0.009 | -0.025 |
| Acquisitions Net
| 0.354 | 0 | -11.714 | -10.514 | -11.245 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -0.354 | 0 | 0 | -4 | -11.245 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0.367 | 0 | 0 | 4 | 11.245 | 0 | 0.934 | 0 | 0.815 | 1.329 | 0 |
| Other Investing Activites
| -1.018 | -4.34 | -13.354 | -0.007 | -0.252 | -0.24 | 0.934 | -0.075 | 0.815 | 1.329 | 0 |
| Investing Cash Flow
| -0.932 | -4.34 | -13.961 | -11.748 | -12.415 | -0.031 | 0.843 | -0.181 | 0.315 | 1.32 | -0.025 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -0.117 | -1.429 | -1.534 | -0.446 | -1.637 | -1.181 | -0.398 | -0.114 | -1.557 | 0 | 0 |
| Common Stock Issued
| 13.421 | 37.236 | 80.527 | 20.805 | 48.85 | 13.295 | 8.384 | 10.55 | 11.649 | 0 | 0 |
| Common Stock Repurchased
| -1.118 | 0 | -0.239 | -0.014 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | -0.096 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 12.303 | 37.235 | 80.137 | 5.04 | 0.655 | 13.295 | 10.366 | -0.555 | 0.004 | 0 | 0 |
| Financing Cash Flow
| 12.186 | 35.806 | 78.364 | 22.799 | 47.868 | 12.114 | 9.968 | 9.881 | 11.653 | 0 | 0 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -12.071 | -14.102 | 28.462 | -14.929 | 15.738 | 0.434 | -2.574 | 2.178 | 7.739 | 0.156 | -0.735 |
| Cash At End Of Period
| 11.132 | 23.203 | 37.305 | 8.843 | 23.772 | 8.034 | 7.6 | 10.174 | 7.996 | 0.257 | 0.101 |